The following studies have contributed to our Cannabis Dependence datasets.
Study 32 – Achieving Cannabis Cessation-Evaluation of N-Acetylcysteine (ACCENT); CTN-0053
Investigator: Kevin M. Gray, M.D. (Medical University of South Carolina) Status: Available at NIDA Repository Release Date: November 2023 View Study in Clinical Trials Network Site Abstract: This study is a 12-week, double-blind, randomized, placebo controlled trial of N-acetylcysteine (NAC) 1200mg twice daily, added to contingency management (CM), for the treatment of cannabis use among treatment-seeking cannabis-dependent adults (18-60). Approximately...